Polarean Imaging Past Earnings Performance

Past criteria checks 0/6

Polarean Imaging's earnings have been declining at an average annual rate of -16.2%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been declining at an average rate of 16.6% per year.

Key information

-16.2%

Earnings growth rate

-0.9%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate-16.6%
Return on equity-54.0%
Net Margin-457.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Oct 16
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Here's Why Polarean Imaging (LON:POLX) Must Use Its Cash Wisely

Jan 09
Here's Why Polarean Imaging (LON:POLX) Must Use Its Cash Wisely

Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Sep 11
Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Feb 09
Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

We're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn Rate

Oct 09
We're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn Rate

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Dec 15
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

We Think Shareholders Will Probably Be Generous With Polarean Imaging plc's (LON:POLX) CEO Compensation

Jul 07
We Think Shareholders Will Probably Be Generous With Polarean Imaging plc's (LON:POLX) CEO Compensation

Here's Why We're Watching Polarean Imaging's (LON:POLX) Cash Burn Situation

Jun 07
Here's Why We're Watching Polarean Imaging's (LON:POLX) Cash Burn Situation

Insider Buying: The Polarean Imaging plc (LON:POLX) Independent Chairman Just Bought 6.6% More Shares

Mar 18
Insider Buying: The Polarean Imaging plc (LON:POLX) Independent Chairman Just Bought 6.6% More Shares

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Mar 09
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Polarean Imaging (LON:POLX) Shareholders Have Enjoyed An Impressive 135% Share Price Gain

Feb 01
Polarean Imaging (LON:POLX) Shareholders Have Enjoyed An Impressive 135% Share Price Gain

Should You Take Comfort From Insider Transactions At Polarean Imaging plc (LON:POLX)?

Dec 28
Should You Take Comfort From Insider Transactions At Polarean Imaging plc (LON:POLX)?

What Type Of Shareholders Own The Most Number of Polarean Imaging plc (LON:POLX) Shares?

Nov 30
What Type Of Shareholders Own The Most Number of Polarean Imaging plc (LON:POLX) Shares?

Revenue & Expenses Breakdown

How Polarean Imaging makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

AIM:POLX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242-954
31 Mar 241-1074
31 Dec 231-1284
30 Sep 231-1385
30 Jun 230-1486
31 Mar 231-1486
31 Dec 221-1476
30 Sep 221-15113
30 Jun 221-16141
31 Mar 221-15140
31 Dec 211-14140
30 Sep 211-11101
30 Jun 211-872
31 Mar 211-761
31 Dec 201-760
30 Sep 202-670
30 Jun 202-670
31 Mar 202-670
31 Dec 192-670
30 Sep 192-670
30 Jun 192-670
31 Mar 192-670
31 Dec 182-560
30 Sep 182-560
30 Jun 182-560
31 Mar 182-450
31 Dec 171-440
31 Dec 161-110
31 Dec 151-110
31 Dec 141010

Quality Earnings: POLX is currently unprofitable.

Growing Profit Margin: POLX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: POLX is unprofitable, and losses have increased over the past 5 years at a rate of 16.2% per year.

Accelerating Growth: Unable to compare POLX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: POLX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (39.9%).


Return on Equity

High ROE: POLX has a negative Return on Equity (-54.03%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 05:07
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Polarean Imaging plc is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Colin SmithCapital Access Group
Christian GlennieStifel, Equities Research
null nullStifel, Equities Research